A case of intraocular coenurosis was clinically diagnosed and treated with praziquantel. The drug destroyed the coenurus, but vision was lost through toxic endophthalmitis and retinal detachment. There were no systemic side effects.
Case report A 25-year-old man was referred on 21 September 1987 because of a one-week history of painful redness and blurring of vision in the right eye. His visual acuity was RE 6/9 and LE 6/5 (Snellen's). The General examination showed no nodules on any part ofthe body. The haemoglobin value was 15 5 g/l, leucocyte count 6x 109/l (neutrophils 45%, lymphocytes 50%, monocytes 2%, and eosinophils 3%). The platelet count was 160x 109/1. Stool examination showed no evidence of parastitic infection. There were no cells in the aqueous humour.
TREATMENT
The patient was treated with topical steroids, and on 5 February 1988 praziquantel was begun at a daily single dose of 25 mg/kg body weight orally for four days. He also received prednisolone tablets, 10 mg three times daily during the same period.
Ten days later he complained of severe pain and redness in the right eye, noting that the balloon he used to see had become smaller; it then disappeared. Fundoscopy showed that the cyst had ruptured, with the nasal wall floating in the vitreous. Only a few ofthe white masses were seen lying on the temporal retina, while some white debris lay on the inferior retina. The vitreous was cloudy and visual acuity was hand movements.
Despite a repeat of the course of praziquantel and prednisolone, the patient went on to develop endophthalnitis. For The best treatment for an intravitreal cestode cystic larva is its removal through a closed vitrectomy.9 This should be carried out whenever possible and as soon as possible. The cyst should be removed while it is still living,'0 because its death leads to the release of large amounts of toxins and severe intraocular inflammation.
We did not have the facilities for closed vitrectomy, and since scleral dissection would not be the best approach for removal of an intravitreous cyst we decided on medical therapy. We chose praziquantel, a schistosomicide, that has proved effective in destroying cysticerci, including those in the brain and with minimal side effects." 12 The drug was easily available at an affordable price. It did prove effective in destroying the coenurus, but the attendant toxic endophthalmitis led to visual loss despite adjuvant systemic steroids. No systemic side effects due to the drug were reported.
Toxic endophthalmitis with its sequelae is the principal mechanism of visual loss when the coenurus is intraocular, but coenurosis can impair vision in other ways. An intracranial coenurus involving the venticular system will lead to symptoms and signs of raised intracranial pressure, including papilloedema. If prolonged, pressure necrosis and visual impairment will ensue. Chiasmal interference or localisation in the cerebral hemispheres will lead to charactersitic visual field defects.
Determination of the particular species to which a coenurus in human infection belongs has been described by Beaver et 
